Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2013

Open Access 01-12-2013 | Research

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation

Authors: Travis J O’Brien, Mariah M Kalmin, Arthur F Harralson, Adam M Clark, Ian Gindoff, Samuel J Simmens, David Frankfurter, Paul Gindoff

Published in: Reproductive Biology and Endocrinology | Issue 1/2013

Login to get access

Abstract

Background

The aim of this study was to determine the relationship between a purported luteinizing hormone/chorionic gonadotropin (LHCGR) high function polymorphism (rs4539842/insLQ) and outcome to controlled ovarian hyperstimulation (COH).

Methods

This was a prospective study of 172 patients undergoing COH at the Fertility and IVF Center at GWU. DNA was isolated from blood samples and a region encompassing the insLQ polymorphism was sequenced. We also investigated a polymorphism (rs4073366 G > C) that was 142 bp from insLQ. The association of the insLQ and rs4073366 alleles and outcome to COH (number of mature follicles, estradiol level on day of human chorionic gonadotropin (hCG) administration, the number of eggs retrieved and ovarian hyperstimulation syndrome (OHSS)) was determined.

Results

Increasing age and higher day 3 (basal) FSH levels were significantly associated with poorer response to COH. We found that both insLQ and rs4073366 were in linkage disequilibrium (LD) and no patients were homozygous for both recessive alleles (insLQ/insLQ; C/C). The insLQ variant was not significantly associated with any of the main outcomes to COH. Carrier status for the rs4073366 C variant was associated (P = 0.033) with an increased risk (OR 2.95, 95% CI = 1.09-7.96) of developing OHSS.

Conclusions

While age and day 3 FSH levels were predictive of outcome, we found no association between insLQ and patient response to COH. Interestingly, rs4073366 C variant carrier status was associated with OHSS risk. To the best of our knowledge, this is the first report suggesting that LHCGR genetic variation might function in patient risk for OHSS.
Literature
1.
Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989, 51: 651-654.PubMed
2.
Licciardi FL, Liu HC, Rosenwaks Z: Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995, 64: 991-994.PubMed
3.
Ficicioglu C, Kutlu T, Baglam E, Bakacak Z: Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006, 85: 592-596. 10.1016/j.fertnstert.2005.09.019.CrossRefPubMed
4.
Hsu A, Arny M, Knee AB, Bell C, Cook E, Novak AL, Grow DR: Antral follicle count in clinical practice: analyzing clinical relevance. Fertil Steril. 2011, 95: 474-479. 10.1016/j.fertnstert.2010.03.023.CrossRefPubMed
5.
Alviggi C, Humaidan P, Ezcurra D: Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol. 2012, 10: 9-10.1186/1477-7827-10-9.PubMedCentralCrossRefPubMed
6.
Altmae S, Hovatta O, Stavreus-Evers A, Salumets A: Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?. Hum Reprod Update. 2011, 17: 813-828. 10.1093/humupd/dmr034.CrossRefPubMed
7.
Anagnostou E, Mavrogianni D, Theofanakis C, Drakakis P, Bletsa R, Demirol A, Gurgan T, Antsaklis A, Loutradis D: ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders. Curr Pharm Biotechnol. 2012, 13: 426-434. 10.2174/138920112799361891.CrossRefPubMed
8.
Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, Taieb S, Wainer R, Benahmed M, De Mazancourt P, et al: Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoS One. 2012, 7: e38700-10.1371/journal.pone.0038700.PubMedCentralCrossRefPubMed
9.
Daelemans C, Smits G, De Maertelaer V, Costagliola S, Englert Y, Vassart G, Delbaere A: Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004, 89: 6310-6315. 10.1210/jc.2004-1044.CrossRefPubMed
10.
De Castro F, Moron FJ, Montoro L, Galan JJ, Hernandez DP, Padilla ES, Ramirez-Lorca R, Real LM, Ruiz A: Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics. 2004, 14: 285-293. 10.1097/00008571-200405000-00003.CrossRefPubMed
11.
Desai SS, Achrekar SK, Pathak BR, Desai SK, Mangoli VS, Mangoli RV, Mahale SD: Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. J Clin Endocrinol Metab. 2011, 96: 2805-2812. 10.1210/jc.2011-1064.CrossRefPubMed
12.
Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, Lee GH, Lee WD, Kim SH, Kim JG, Moon SY: Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet. 2006, 51: 665-670. 10.1007/s10038-006-0005-5.CrossRefPubMed
13.
Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, Makrigiannakis A: FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet. 2006, 23: 177-184. 10.1007/s10815-005-9015-z.PubMedCentralCrossRefPubMed
14.
Lussiana C, Guani B, Mari C, Restagno G, Massobrio M, Revelli A: Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv. 2008, 63: 785-795. 10.1097/OGX.0b013e31818957eb.CrossRefPubMed
15.
Sheikhha MH, Eftekhar M, Kalantar SM: Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci. 2011, 4: 86-90. 10.4103/0974-1208.86089.PubMedCentralCrossRefPubMed
16.
Wunsch A, Ahda Y, Banaz-Yasar F, Sonntag B, Nieschlag E, Simoni M, Gromoll J: Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril. 2005, 84: 446-453. 10.1016/j.fertnstert.2005.02.031.CrossRefPubMed
17.
Wunsch A, Sonntag B, Simoni M: Polymorphism of the FSH receptor and ovarian response to FSH. Ann Endocrinol (Paris). 2007, 68: 160-166. 10.1016/j.ando.2007.04.006.CrossRef
18.
Altmae S, Haller K, Peters M, Hovatta O, Stavreus-Evers A, Karro H, Metspalu A, Salumets A: Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol Hum Reprod. 2007, 13: 521-526. 10.1093/molehr/gam035.CrossRefPubMed
19.
Georgiou I, Konstantelli M, Syrrou M, Messinis IE, Lolis DE: Oestrogen receptor gene polymorphisms and ovarian stimulation for in-vitro fertilization. Hum Reprod. 1997, 12: 1430-1433. 10.1093/humrep/12.7.1430.CrossRefPubMed
20.
Loutradis D, Theofanakis C, Anagnostou E, Mavrogianni D, Partsinevelos GA: Genetic profile of SNP(s) and ovulation induction. Curr Pharm Biotechnol. 2012, 13: 417-425. 10.2174/138920112799361954.CrossRefPubMed
21.
Altmae S, Haller K, Peters M, Saare M, Hovatta O, Stavreus-Evers A, Velthut A, Karro H, Metspalu A, Salumets A: Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome: a preliminary report. Reprod Biomed Online. 2009, 18: 651-657. 10.1016/S1472-6483(10)60009-0.CrossRefPubMed
22.
Wang TT, Wu YT, Dong MY, Sheng JZ, Leung PC, Huang HF: G546A polymorphism of growth differentiation factor-9 contributes to the poor outcome of ovarian stimulation in women with diminished ovarian reserve. Fertil Steril. 2010, 94: 2490-2492. 10.1016/j.fertnstert.2010.03.070.CrossRefPubMed
23.
Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA: A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation. Reprod Biomed Online. 2011, 23: 97-104. 10.1016/j.rbmo.2011.02.015.CrossRefPubMed
24.
Hillier SG: Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol. 2001, 179: 39-46. 10.1016/S0303-7207(01)00469-5.CrossRefPubMed
25.
Webb R, Nicholas B, Gong JG, Campbell BK, Gutierrez CG, Garverick HA, Armstrong DG: Mechanisms regulating follicular development and selection of the dominant follicle. Reprod Suppl. 2003, 61: 71-90.PubMed
26.
Ziecik AJ, Kaczmarek MM, Blitek A, Kowalczyk AE, Li X, Rahman NA: Novel biological and possible applicable roles of LH/hCG receptor. Mol Cell Endocrinol. 2007, 269: 51-60. 10.1016/j.mce.2006.08.016.CrossRefPubMed
27.
Ziecik AJ, Derecka-Reszka K, Rzucidlo SJ: Extragonadal gonadotropin receptors, their distribution and function. J Physiol Pharmacol. 1992, 43: 33-49.PubMed
28.
Ziecik AJ, Derecka K, Gawronska B, Stepien A, Bodek G: Nongonadal LH/hCG receptors in pig: functional importance and parallels to human. Semin Reprod Med. 2001, 19: 19-30. 10.1055/s-2001-13907.CrossRefPubMed
29.
Gawronska B, Paukku T, Huhtaniemi I, Wasowicz G, Ziecik AJ: Oestrogen-dependent expression of LH/hCG receptors in pig Fallopian tube and their role in relaxation of the oviduct. J Reprod Fertil. 1999, 115: 293-301. 10.1530/jrf.0.1150293.CrossRefPubMed
30.
Perrier d’Hauterive S, Berndt S, Tsampalas M, Charlet-Renard C, Dubois M, Bourgain C, Hazout A, Foidart JM, Geenen V: Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation?. Gynecol Obstet Invest. 2007, 64: 156-160. 10.1159/000101740.CrossRefPubMed
31.
Hearn MT, Gomme PT: Molecular architecture and biorecognition processes of the cystine knot protein superfamily: part I. The glycoprotein hormones. J Mol Recognit. 2000, 13: 223-278. 10.1002/1099-1352(200009/10)13:5<223::AID-JMR501>3.0.CO;2-L.CrossRefPubMed
32.
Ascoli M, Fanelli F, Segaloff DL: The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002, 23: 141-174. 10.1210/er.23.2.141.CrossRefPubMed
33.
34.
Cerrillo M, Pacheco A, Rodriguez S, Gomez R, Delgado F, Pellicer A, Garcia-Velasco JA: Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome. Fertil Steril. 2011, 95: 2517-2519. 10.1016/j.fertnstert.2010.12.054.CrossRefPubMed
35.
Vardhana PA, Julius MA, Pollak SV, Lustbader EG, Trousdale RK, Lustbader JW: A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats. Endocrinology. 2009, 150: 3807-3814. 10.1210/en.2009-0107.PubMedCentralCrossRefPubMed
36.
Van de Lagemaat R, Raafs BC, Van Koppen C, Timmers CM, Mulders SM, Hanssen RG: Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH. Endocrinology. 2011, 152: 4350-4357. 10.1210/en.2011-1077.CrossRefPubMed
37.
Fanelli F, Puett D: Structural aspects of luteinizing hormone receptor: information from molecular modeling and mutagenesis. Endocrine. 2002, 18: 285-293. 10.1385/ENDO:18:3:285.CrossRefPubMed
38.
Fanelli F, Themmen AP, Puett D: Lutropin receptor function: insights from natural, engineered, and computer-simulated mutations. IUBMB Life. 2001, 51: 149-155. 10.1080/152165401753544214.CrossRefPubMed
39.
Fanelli F, Verhoef-Post M, Timmerman M, Zeilemaker A, Martens JW, Themmen AP: Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398. Mol Endocrinol. 2004, 18: 1499-1508. 10.1210/me.2003-0050.CrossRefPubMed
40.
Themmen AP: An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reprod Suppl. 2005, 130: 263-274.CrossRef
41.
Minegishi T, Nakamura K, Takakura Y, Miyamoto K, Hasegawa Y, Ibuki Y, Igarashi M, Minegish T: Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commun. 1990, 172: 1049-1054. 10.1016/0006-291X(90)91552-4.CrossRefPubMed
42.
Atger M, Misrahi M, Sar S, Le Flem L, Dessen P, Milgrom E: Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5’ non-coding regions. Mol Cell Endocrinol. 1995, 111: 113-123. 10.1016/0303-7207(95)03557-N.CrossRefPubMed
43.
Mongan NP, Hughes IA, Lim HN: Evidence that luteinising hormone receptor polymorphisms may contribute to male undermasculinisation. Eur J Endocrinol. 2002, 147: 103-107. 10.1530/eje.0.1470103.CrossRefPubMed
44.
Bentov Y, Kenigsberg S, Casper RF: A novel luteinizing hormone/chorionic gonadotropin receptor mutation associated with amenorrhea, low oocyte yield, and recurrent pregnancy loss. Fertil Steril. 2012, 97: 1165-1168. 10.1016/j.fertnstert.2012.02.002.CrossRefPubMed
45.
Simoni M, Tuttelmann F, Michel C, Bockenfeld Y, Nieschlag E, Gromoll J: Polymorphisms of the luteinizing hormone/chorionic gonadotropin receptor gene: association with maldescended testes and male infertility. Pharmacogenet Genomics. 2008, 18: 193-200. 10.1097/FPC.0b013e3282f4e98c.CrossRefPubMed
46.
Kossack N, Troppmann B, Richter-Unruh A, Kleinau G, Gromoll J: Aberrant transcription of the LHCGR gene caused by a mutation in exon 6A leads to Leydig cell hypoplasia type II. Mol Cell Endocrinol. 2013, 366: 59-67. 10.1016/j.mce.2012.11.018.CrossRefPubMed
47.
Latronico AC, Arnhold IJ: Inactivating mutations of the human luteinizing hormone receptor in both sexes. Semin Reprod Med. 2012, 30: 382-386. 10.1055/s-0032-1324721.CrossRefPubMed
48.
Yariz KO, Walsh T, Uzak A, Spiliopoulos M, Duman D, Onalan G, King MC, Tekin M: Inherited mutation of the luteinizing hormone/choriogonadotropin receptor (LHCGR) in empty follicle syndrome. Fertil Steril. 2011, 96: e125-130. 10.1016/j.fertnstert.2011.05.057.PubMedCentralCrossRefPubMed
49.
Qiao J, Han B, Liu BL, Chen X, Ru Y, Cheng KX, Chen FG, Zhao SX, Liang J, Lu YL, et al: A splice site mutation combined with a novel missense mutation of LHCGR cause male pseudohermaphroditism. Hum Mutat. 2009, 30: E855-865. 10.1002/humu.21072.CrossRefPubMed
50.
Arnhold IJ, Lofrano-Porto A, Latronico AC: Inactivating mutations of luteinizing hormone beta-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women. Horm Res. 2009, 71: 75-82.CrossRefPubMed
51.
Segaloff DL: Diseases associated with mutations of the human lutropin receptor. Prog Mol Biol Transl Sci. 2009, 89: 97-114.CrossRefPubMed
52.
Piersma D, Berns EM, Verhoef-Post M, Uitterlinden AG, Braakman I, Pols HA, Themmen AP: A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. J Clin Endocrinol Metab. 2006, 91: 1470-1476. 10.1210/jc.2005-2156.CrossRefPubMed
53.
Piersma D, Themmen AP, Look MP, Klijn JG, Foekens JA, Uitterlinden AG, Pols HA, Berns EM: GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients. Breast Cancer Res. 2007, 9: R51-10.1186/bcr1756.PubMedCentralCrossRefPubMed
54.
Rodien P, Cetani F, Costagliola S, Tonacchera M, Duprez L, Minegishi T, Govaerts C, Vassart G: Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors. J Clin Endocrinol Metab. 1998, 83: 4431-4434. 10.1210/jc.83.12.4431.PubMed
55.
Tsai-Morris CH, Geng Y, Buczko E, Dehejia A, Dufau ML: Genomic distribution and gonadal mRNA expression of two human luteinizing hormone receptor exon 1 sequences in random populations. Hum Hered. 1999, 49: 48-51. 10.1159/000022840.CrossRefPubMed
56.
Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J, et al: Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011, 43: 55-59. 10.1038/ng.732.CrossRefPubMed
57.
Kerkela E, Skottman H, Friden B, Bjuresten K, Kere J, Hovatta O: Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertil Steril. 2007, 87: 603-606. 10.1016/j.fertnstert.2006.06.060.CrossRefPubMed
58.
Bergh PA, Navot D: Ovarian hyperstimulation syndrome: a review of pathophysiology. J Assist Reprod Genet. 1992, 9: 429-438. 10.1007/BF01204048.CrossRefPubMed
59.
Navot D, Bergh PA, Laufer N: Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992, 58: 249-261.PubMed
60.
Westfall PH, Wolfinger RD: Closed multiple testing procedures and PROC MULTTEST. 2000, Estados Unidos: Observations SAS Institute Inc.
61.
Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G: PyPop update–a software pipeline for large-scale multilocus population genomics. Tissue Antigens. 2007, 69 (Suppl 1): 192-197.PubMedCentralCrossRefPubMed
62.
Gaunt TR, Rodriguez S, Day IN: Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool ‘CubeX’. BMC Bioinformatics. 2007, 8: 428-10.1186/1471-2105-8-428.PubMedCentralCrossRefPubMed
63.
Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD: Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women. Fertil Steril. 2009, 91: 432-439. 10.1016/j.fertnstert.2007.11.093.CrossRefPubMed
64.
d’Alva CB, Serafini P, Motta E, Kohek MB, Latronico AC, Mendonca BB: Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome. Fertil Steril. 2005, 83: 1695-1699. 10.1016/j.fertnstert.2004.12.044.CrossRefPubMed
65.
Moron FJ, De Castro F, Royo JL, Montoro L, Mira E, Saez ME, Real LM, Gonzalez A, Manes S, Ruiz A: Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS). Pharmacogenet Genomics. 2006, 16: 485-495. 10.1097/01.fpc.0000215073.44589.96.CrossRefPubMed
66.
Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA: Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor +405 cc genotype. Gynecol Endocrinol. 2012, 28: 845-849. 10.3109/09513590.2012.683056.CrossRefPubMed
67.
Haasl RJ, Ahmadi MR, Meethal SV, Gleason CE, Johnson SC, Asthana S, Bowen RL, Atwood CS: A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer’s disease in males carrying an apolipoprotein E epsilon4 allele. BMC Med Genet. 2008, 9: 37-PubMedCentralCrossRefPubMed
68.
Corbo RM, Ulizzi L, Scacchi R, Martinez-Labarga C, De Stefano GF: Apolipoprotein E polymorphism and fertility: a study in pre-industrial populations. Mol Hum Reprod. 2004, 10: 617-620. 10.1093/molehr/gah082.CrossRefPubMed
69.
Corbo RM, Ulizzi L, Piombo L, Scacchi R: Study on a possible effect of four longevity candidate genes (ACE, PON1, PPAR-gamma, and APOE) on human fertility. Biogerontology. 2008, 9: 317-323. 10.1007/s10522-008-9143-9.CrossRefPubMed
70.
Corbo RM, Scacchi R, Cresta M: Differential reproductive efficiency associated with common apolipoprotein e alleles in postreproductive-aged subjects. Fertil Steril. 2004, 81: 104-107. 10.1016/j.fertnstert.2003.05.029.CrossRefPubMed
Metadata
Title
Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
Authors
Travis J O’Brien
Mariah M Kalmin
Arthur F Harralson
Adam M Clark
Ian Gindoff
Samuel J Simmens
David Frankfurter
Paul Gindoff
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2013
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-11-71

Other articles of this Issue 1/2013

Reproductive Biology and Endocrinology 1/2013 Go to the issue

Research

Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study

Short communication

Exogenous gonadotropins do not increase the blood-follicular transportation capacity of extra-ovarian hormones such as prolactin and cortisol

Research

Morphometric analysis of the placenta in the New World mouse Necromys lasiurus(Rodentia, Cricetidae): a comparison of placental development in cricetids and murids

Research

Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitroby ghrelin

Research

Effects of partial or complete laser-assisted hatching on the hatching of mouse blastocysts and their cell numbers

Research

Neonatal outcomes after the transfer of vitrified blastocysts: closed versus open vitrification system